Clinical Trials Logo
  1. Home
  2. Vestibular Neuritis
  3. NCT04926363

Prevalence of Cardiovascular Risk Factors in Upper Vestibular Neuritis — NEVRITE  

Vestibular Neuritis Clinical Trial

Official title:
Prevalence of Cardiovascular Risk Factors in People With Upper Vestibular Neuritis

Clinical Trial Summary

Vestibular neuritis is the second cause of vertigo, it constitutes 5 to 6% of the aetiologies of vertigo in an otoneurological consultation. Infection or reactivation of a neurotropic virus of the herpes group (HSV-1) in the vestibular lymph node is thought to be the cause of the unilateral vestibular deficit. Upper vestibular neuritis is more common than lower, or total involvement. Goebel (2) explains this by an anatomical predisposition of the vestibular nerve canal to inflammation, unlike the singular nerve canal which is shorter and wider giving way to a certain degree of edema without consequence on its contents. However, the innervation territory of the superior vestibular nerve is superimposable on the territory supplied by the anterior vestibular artery. The anterior, lateral semicircular canals and the utricle are affected. Current complementary vestibular and imaging examinations cannot differentiate between inflammatory or vascular involvement in upper vestibular neuritis. The increased presence of cardiovascular risk factors in patients with upper vestibular neuritis would be an argument in favor of ischemic involvement of the anterior vestibular artery.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04926363
Study type Observational
Source University Hospital, Strasbourg, France
Contact Anne CHARPIOT, MD, PhD
Phone 33 3 88 12 76 41
Email anne.charpiot@chru-strasbourg.fr
Status Recruiting
Phase
Start date February 1, 2020
Completion date February 4, 2022
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02655575 - Assessment and Treatment of Patients With Long-term Dizziness in Primary Care N/A
Completed NCT05157399 - Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness N/A
Completed NCT02098330 - The Efficacy of Steroid Therapy in Vestibular Neuritis Phase 3
Recruiting NCT04678167 - Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis N/A
Not yet recruiting NCT05424302 - Effect of Peripheral Vestibular Disease Location on Outcomes Following Home-based Virtual Reality Vestibular Therapy N/A
Recruiting NCT01231009 - The Role of Corticosteroids and Vestibular Exercises in Recovery of Vestibular Neuritis Phase 0
Completed NCT03452410 - MRIPositive Diagnosis of Vestibular Neuritis Using Fluid Attenuated Inversion Recuperation (FLAIR) Sequence on a 1.5 Tesla
Completed NCT03821155 - Does Vestibular Rehabilitation Significantly Improve the Level of Vestibular Function Following Vestibular Neuritis? N/A
Recruiting NCT04935970 - Metabolic Disorders and Vertigo
Completed NCT02171312 - Clinical Evaluation of a Novel Balance, Vestibular and Oculomotor Assessment Tool N/A